CARLI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 407
EU - Europa 313
AS - Asia 101
AF - Africa 35
SA - Sud America 6
Totale 862
Nazione #
US - Stati Uniti d'America 404
IT - Italia 219
SG - Singapore 50
CN - Cina 40
SE - Svezia 32
CI - Costa d'Avorio 26
DE - Germania 19
BG - Bulgaria 17
SN - Senegal 9
BR - Brasile 6
FR - Francia 6
GB - Regno Unito 6
TR - Turchia 4
CA - Canada 3
FI - Finlandia 3
RU - Federazione Russa 3
VN - Vietnam 3
AT - Austria 2
HK - Hong Kong 2
CH - Svizzera 1
CZ - Repubblica Ceca 1
GR - Grecia 1
IE - Irlanda 1
IN - India 1
JP - Giappone 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 862
Città #
Chandler 54
Fairfield 47
Santa Clara 31
Ashburn 29
Abidjan 26
Singapore 26
Woodbridge 26
New York 19
Seattle 18
Boardman 17
Sofia 16
Cambridge 15
Florence 14
Wilmington 12
Pisa 11
Milan 10
Princeton 10
Serra 10
Dakar 9
Bremen 8
Houston 8
Lawrence 8
Frankfurt am Main 7
Ogden 7
Shanghai 7
Ann Arbor 5
Beijing 5
Des Moines 5
Rome 5
Apucarana 4
Boulder 4
Medford 4
Cascina 3
Dearborn 3
Ferrara 3
Istanbul 3
Lancaster 3
Los Angeles 3
Norwalk 3
Ottawa 3
San Diego 3
Shenzhen 3
Avellino 2
Bologna 2
Bolzano 2
Brembilla 2
Cagliari 2
Camaiore 2
Castelfranco Di Sotto 2
Council Bluffs 2
Fauglia 2
Hong Kong 2
Jesi 2
Livorno 2
London 2
Munich 2
Quanzhou 2
Redwood City 2
Rio Saliceto 2
Sesto San Giovanni 2
Trento 2
Vienna 2
Acerra 1
Boydton 1
Brno 1
Casalfiumanese 1
Catania 1
Changsha 1
Dallas 1
Dong Ket 1
Dublin 1
Fuzhou 1
Gaston 1
Guangzhou 1
Helsinki 1
Kent 1
Kocaeli 1
L'aquila 1
La Canada Flintridge 1
Lappeenranta 1
Lucca 1
Nanchang 1
Nanjing 1
Piemonte 1
Pune 1
Round Rock 1
Schoftland 1
Shenyang 1
São Paulo 1
Torino 1
Trieste 1
Tyler 1
Venezia 1
Warsaw 1
Zhengzhou 1
Totale 580
Nome #
Is Trazodone Contramid Useful in Inducing Patients to Refrain from Using Cocaine after Detoxification, so Avoiding Early Relapse? A Case Series 260
Dopamine D2 receptors dimers: how can we pharmacologically target them? 140
Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences 100
β-Cells Different Vulnerability to the Parkinsonian Neurotoxins Rotenone, 1-Methyl-4-phenylpyridinium (MPP+) and 6-Hydroxydopamine (6-OHDA) 62
Opioid receptors beyond pain control: The role in cancer pathology and the debated importance of their pharmacological modulation 56
Substance use disorder in adult-attention deficit hyperactive disorder patients: Patterns of use and related clinical features 54
Atypical antipsychotics and metabolic syndrome: From molecular mechanisms to clinical differences 49
Does cannabis, cocaine and alcohol use impact differently on adult attention deficit/hyperactivity disorder clinical picture? 40
Valproate and lithium: Old drugs for new pharmacological approaches in brain tumors? 30
Triple Diagnosis of Attention-Deficit/Hyperactivity Disorder with Coexisting Bipolar and Alcohol Use Disorders: Clinical Aspects and Pharmacological Treatments 23
A 5-Year Study of Antiseizure Medications (ASMs) Monitoring in Patients with Neuropsychiatric Disorders in an Italian Clinical Center 22
Long-term treatment of adult ADHD in a naturalistic setting: Clinical predictors of attrition, medication choice, improvement, and response 17
Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib 16
Methadone dose escalation in patients with opioid use disorder and cancer as a strategy for controlling cancer-related pain: A case series 10
Dopamine-mediated autocrine inhibition of insulin secretion 8
Totale 887
Categoria #
all - tutte 3.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.484


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202087 0 0 0 0 10 13 19 15 10 5 9 6
2020/202190 2 5 8 6 3 7 7 6 15 15 8 8
2021/202298 2 4 3 5 10 19 9 10 4 9 6 17
2022/2023192 15 20 16 11 13 26 1 15 57 1 7 10
2023/2024145 10 5 19 7 15 23 7 16 3 4 22 14
2024/2025109 5 15 13 42 34 0 0 0 0 0 0 0
Totale 887